These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16537682)

  • 21. Estradiol supplementation modulates growth hormone (GH) secretory-burst waveform and recombinant human insulin-like growth factor-I-enforced suppression of endogenously driven GH release in postmenopausal women.
    Veldhuis JD; Anderson SM; Kok P; Iranmanesh A; Frystyk J; Ørskov H; Keenan DM
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1312-8. PubMed ID: 15001627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arginine counteracts the inhibitory effect of recombinant human insulin-like growth factor I on the somatotroph responsiveness to growth hormone-releasing hormone in humans.
    Gianotti L; Maccario M; Lanfranco F; Ramunni J; Di Vito L; Grottoli S; Muller EE; Ghigo E; Arvat E
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3604-8. PubMed ID: 11061509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Twenty-four hour continuous ghrelin infusion augments physiologically pulsatile, nycthemeral, and entropic (feedback-regulated) modes of growth hormone secretion.
    Veldhuis JD; Reynolds GA; Iranmanesh A; Bowers CY
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3597-603. PubMed ID: 18593763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low plasma ghrelin level in gastrectomized patients is accompanied by enhanced sensitivity to the ghrelin-induced growth hormone release.
    Popovic V; Miljic D; Pekic S; Pesko P; Djurovic M; Doknic M; Damjanovic S; Micic D; Cvijovic G; Glodic J; Dieguez C; Casanueva FF
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2187-91. PubMed ID: 15644398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion.
    Alba-Roth J; Müller OA; Schopohl J; von Werder K
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1186-9. PubMed ID: 2903866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Corticotropin-releasing hormone inhibition of growth hormone-releasing hormone-induced growth hormone release in man.
    Barbarino A; Corsello SM; Della Casa S; Tofani A; Sciuto R; Rota CA; Bollanti L; Barini A
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1368-74. PubMed ID: 2229294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Marked GH secretion after ghrelin alone or combined with GH-releasing hormone (GHRH) in obese patients.
    Alvarez-Castro P; Isidro ML; Garcia-Buela J; Leal-Cerro A; Broglio F; Tassone F; Ghigo E; Dieguez C; Casanueva FF; Cordido F
    Clin Endocrinol (Oxf); 2004 Aug; 61(2):250-5. PubMed ID: 15272922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of somatostatin-receptor subtype-2/-5 suppresses the mass, frequency, and irregularity of growth hormone (GH)-releasing peptide-2-stimulated GH secretion in men.
    Iranmanesh A; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4581-7. PubMed ID: 15356066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen supplementation selectively enhances hypothalamo-pituitary sensitivity to ghrelin in postmenopausal women.
    Kok P; Paulo RC; Cosma M; Mielke KL; Miles JM; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4020-6. PubMed ID: 18611978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prandial regulation of ghrelin secretion in humans: does glucagon contribute to the preprandial increase in circulating ghrelin?
    Soule S; Pemberton C; Hunt P; Cole D; Raudsepp S; Inder W
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):412-7. PubMed ID: 16181233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ghrelin alone or co-administered with GHRH or CRH increases non-REM sleep and decreases REM sleep in young males.
    Kluge M; Schüssler P; Bleninger P; Kleyer S; Uhr M; Weikel JC; Yassouridis A; Zuber V; Steiger A
    Psychoneuroendocrinology; 2008 May; 33(4):497-506. PubMed ID: 18329818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ghrelin administered in the early morning increases secretion of cortisol and growth hormone without affecting sleep.
    Kluge M; Schüssler P; Zuber V; Yassouridis A; Steiger A
    Psychoneuroendocrinology; 2007 Apr; 32(3):287-92. PubMed ID: 17317021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical pharmacology of human growth hormone and its secretagogues.
    Root AW; Root MJ
    Curr Drug Targets Immune Endocr Metabol Disord; 2002 Apr; 2(1):27-52. PubMed ID: 12477295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic regulation of growth hormone by free fatty acids, somatostatin, and ghrelin in HIV-lipodystrophy.
    Koutkia P; Meininger G; Canavan B; Breu J; Grinspoon S
    Am J Physiol Endocrinol Metab; 2004 Feb; 286(2):E296-303. PubMed ID: 14559725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth hormone (GH)-releasing hormone (GHRH) and the GH secretagogue (GHS), L692,585, differentially modulate rat pituitary GHS receptor and GHRH receptor messenger ribonucleic acid levels.
    Kineman RD; Kamegai J; Frohman LA
    Endocrinology; 1999 Aug; 140(8):3581-6. PubMed ID: 10433214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tripartite control of growth hormone secretion in women during controlled estradiol repletion.
    Veldhuis JD; Cosma M; Erickson D; Paulo R; Mielke K; Farhy LS; Bowers CY
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2336-45. PubMed ID: 17405836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preliminary evidence that Ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans.
    Arvat E; Di Vito L; Broglio F; Papotti M; Muccioli G; Dieguez C; Casanueva FF; Deghenghi R; Camanni F; Ghigo E
    J Endocrinol Invest; 2000 Sep; 23(8):493-5. PubMed ID: 11021763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state.
    Broglio F; Gianotti L; Destefanis S; Fassino S; Abbate Daga G; Mondelli V; Lanfranco F; Gottero C; Gauna C; Hofland L; Van der Lely AJ; Ghigo E
    Clin Endocrinol (Oxf); 2004 May; 60(5):592-9. PubMed ID: 15104562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GH secretion is impaired in patients with primary hyperparathyroidism.
    Gasperi M; Cecconi E; Grasso L; Bartalena L; Centoni R; Aimaretti G; Broglio F; Miccoli P; Marcocci C; Ghigo E; Martino E
    J Clin Endocrinol Metab; 2002 May; 87(5):1961-4. PubMed ID: 11994325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interrelationship between the novel peptide ghrelin and somatostatin/growth hormone-releasing hormone in regulation of pulsatile growth hormone secretion.
    Tannenbaum GS; Epelbaum J; Bowers CY
    Endocrinology; 2003 Mar; 144(3):967-74. PubMed ID: 12586774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.